WO2008006106A3 - Methods for preventing, postponing or improving the outcome of invasive spinal procedures - Google Patents

Methods for preventing, postponing or improving the outcome of invasive spinal procedures Download PDF

Info

Publication number
WO2008006106A3
WO2008006106A3 PCT/US2007/073067 US2007073067W WO2008006106A3 WO 2008006106 A3 WO2008006106 A3 WO 2008006106A3 US 2007073067 W US2007073067 W US 2007073067W WO 2008006106 A3 WO2008006106 A3 WO 2008006106A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
outcome
improving
preventing
postponing
Prior art date
Application number
PCT/US2007/073067
Other languages
French (fr)
Other versions
WO2008006106A2 (en
Inventor
James R Gorman
Original Assignee
Bioassets Dev Corp
James R Gorman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioassets Dev Corp, James R Gorman filed Critical Bioassets Dev Corp
Priority to US12/307,900 priority Critical patent/US20100040609A1/en
Priority to CA 2692428 priority patent/CA2692428A1/en
Publication of WO2008006106A2 publication Critical patent/WO2008006106A2/en
Publication of WO2008006106A3 publication Critical patent/WO2008006106A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Methods for identifying subjects who could benefit therapeutically from administration of a targeted anti-inflammatory therapy (TAT) are provided. Subjects that are identified include those that are eligible, based on pre-determined criteria, for a spinal surgery procedure, such as a laminectomy or diskectomy. Methods of preventing such procedures or improving the outcome of such procedures are also provided, and include administering a TAT to the subject by any route or regimen of administration, including both known and novel regimens described herein.
PCT/US2007/073067 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of invasive spinal procedures WO2008006106A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/307,900 US20100040609A1 (en) 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of invasive spinal procedures
CA 2692428 CA2692428A1 (en) 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of invasive spinal procedures

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81955506P 2006-07-07 2006-07-07
US60/819,555 2006-07-07
US84749306P 2006-09-27 2006-09-27
US60/847,493 2006-09-27

Publications (2)

Publication Number Publication Date
WO2008006106A2 WO2008006106A2 (en) 2008-01-10
WO2008006106A3 true WO2008006106A3 (en) 2008-12-18

Family

ID=38895521

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2007/073092 WO2008006118A2 (en) 2006-07-07 2007-07-09 Novel regimens for treating diseases and disorders
PCT/US2007/073089 WO2008006117A2 (en) 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures
PCT/US2007/073067 WO2008006106A2 (en) 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of invasive spinal procedures

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PCT/US2007/073092 WO2008006118A2 (en) 2006-07-07 2007-07-09 Novel regimens for treating diseases and disorders
PCT/US2007/073089 WO2008006117A2 (en) 2006-07-07 2007-07-09 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures

Country Status (3)

Country Link
US (6) US20100047235A1 (en)
CA (3) CA2692428A1 (en)
WO (3) WO2008006118A2 (en)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45976E1 (en) 1999-02-24 2016-04-19 Tact Ip, Llc Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally
US6982089B2 (en) 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US8119127B2 (en) 1999-02-24 2012-02-21 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) * 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
GB0414054D0 (en) 2004-06-23 2004-07-28 Owen Mumford Ltd Improvements relating to automatic injection devices
US8236306B2 (en) 2004-12-18 2012-08-07 Edward Lewis Tobinick Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
CA2651992A1 (en) * 2006-06-30 2008-01-10 Abbott Biotechnology Ltd. Automatic injection device
CA2692428A1 (en) * 2006-07-07 2008-01-10 James R. Gorman Methods for preventing, postponing or improving the outcome of invasive spinal procedures
US20080097229A1 (en) * 2006-08-29 2008-04-24 Josee Roy Hygroscopic treatment for degenerating discs
US20080161929A1 (en) 2006-12-29 2008-07-03 Mccormack Bruce Cervical distraction device
US20100233137A1 (en) * 2007-02-27 2010-09-16 Lanx, Inc. Compositions and Methods for Modification of Target Cells and to Their Uses Thereof
CN101668531B (en) 2007-02-28 2014-05-07 默沙东公司 Combination therapy for treatment of immune disorders
WO2008151119A2 (en) * 2007-06-01 2008-12-11 Lanx, Llc Compositions and methods for use of scar tissue in repair of weight bearing surfaces
US8092541B2 (en) * 2007-08-03 2012-01-10 Warsaw Orthopedic, Inc. Method of using an anti-growth matrix as a barrier for cell attachment and osteo-inductive factors
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US9005288B2 (en) 2008-01-09 2015-04-14 Providence Medical Techonlogy, Inc. Methods and apparatus for accessing and treating the facet joint
WO2009091811A1 (en) 2008-01-14 2009-07-23 Brenzel Michael P Apparatus and methods for fracture repair
WO2009105606A1 (en) * 2008-02-21 2009-08-27 Lanx, Llc Compositions and methods for use of scar tissue in repair of weight bearing surfaces
US20090263456A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Methods and Compositions for Reducing Preventing and Treating Adhesives
US20090263443A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedics, Inc. Methods for treating post-operative effects such as spasticity and shivering with clondine
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US20090264489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US8267966B2 (en) * 2008-06-06 2012-09-18 Providence Medical Technology, Inc. Facet joint implants and delivery tools
US9333086B2 (en) 2008-06-06 2016-05-10 Providence Medical Technology, Inc. Spinal facet cage implant
CA2725811A1 (en) 2008-06-06 2009-12-10 Providence Medical Technology, Inc. Facet joint implants and delivery tools
EP2361046B1 (en) * 2008-06-06 2019-04-24 Providence Medical Technology, Inc. Cervical distraction/implant delivery device
US11224521B2 (en) 2008-06-06 2022-01-18 Providence Medical Technology, Inc. Cervical distraction/implant delivery device
US9381049B2 (en) 2008-06-06 2016-07-05 Providence Medical Technology, Inc. Composite spinal facet implant with textured surfaces
US8361152B2 (en) 2008-06-06 2013-01-29 Providence Medical Technology, Inc. Facet joint implants and delivery tools
US9492375B2 (en) 2008-07-23 2016-11-15 Warsaw Orthopedic, Inc. Foam carrier for bone grafting
EP2334315B1 (en) 2008-09-03 2023-01-18 NoNO Inc. Agents and methods for treatment of pain
US9149319B2 (en) * 2008-09-23 2015-10-06 Lanx, Llc Methods and compositions for stabilization of a vertebra
WO2010036961A1 (en) * 2008-09-25 2010-04-01 Invivo Therapeutics Corporation Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
US20100226959A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Matrix that prolongs growth factor release
US20100228097A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Methods and compositions to diagnose pain
BRPI1012162A2 (en) 2009-04-29 2016-01-12 Abbott Biotech Ltd automatic injection device
SG176000A1 (en) * 2009-05-13 2011-12-29 Protein Delivery Solutions Llc Pharmaceutical system for trans-membrane delivery
US8653029B2 (en) 2009-07-30 2014-02-18 Warsaw Orthopedic, Inc. Flowable paste and putty bone void filler
US8597192B2 (en) 2009-10-30 2013-12-03 Warsaw Orthopedic, Inc. Ultrasonic devices and methods to diagnose pain generators
TWI619521B (en) * 2009-12-15 2018-04-01 艾伯維生物技術有限責任公司 Automatic injection device, automatic injection method and method for preventing misfiring
WO2011088172A1 (en) 2010-01-15 2011-07-21 Brenzel Michael P Rotary-rigid orthopaedic rod
AU2011207550B2 (en) 2010-01-20 2016-03-10 Conventus Orthopaedics, Inc. Apparatus and methods for bone access and cavity preparation
US8475824B2 (en) * 2010-01-26 2013-07-02 Warsaw Orthopedic, Inc. Resorbable matrix having elongated particles
US8758791B2 (en) * 2010-01-26 2014-06-24 Warsaw Orthopedic, Inc. Highly compression resistant matrix with porous skeleton
WO2011112619A1 (en) * 2010-03-08 2011-09-15 Krinke Todd A Apparatus and methods for bone repair
EP2544608A4 (en) 2010-03-08 2017-02-22 Conventus Orthopaedics, Inc. Apparatus and methods for securing a bone implant
US9526600B2 (en) * 2010-07-20 2016-12-27 Warsaw Orthopedic, Inc. Biodegradable stents and methods for treating periodontal disease
EP3187216B1 (en) 2011-01-24 2019-08-21 AbbVie Biotechnology Ltd. Automatic injection devices having overmolded gripping surfaces
US9060978B2 (en) * 2011-01-24 2015-06-23 Warsaw Orthopedic, Inc. Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
US9717779B2 (en) 2011-01-31 2017-08-01 Warsaw Orthopedic, Inc. Implantable matrix having optimum ligand concentrations
US20140178293A1 (en) * 2011-05-06 2014-06-26 Baylor College Of Medicine Methods for imaging bone precursor cells using dual-labeled imaging agents to detect mmp-9 positive cells
WO2012154567A2 (en) * 2011-05-06 2012-11-15 Albert Einstein College Of Medicine Of Yeshiva University Human invasion signature for prognosis of metastatic risk
WO2013169382A1 (en) * 2012-05-07 2013-11-14 DePuy Synthes Products, LLC Methods and devices for treating intervertebral disc disease
US20150157692A1 (en) * 2012-05-23 2015-06-11 The University Of Chicago Methods of treating obesity
USD745156S1 (en) 2012-10-23 2015-12-08 Providence Medical Technology, Inc. Spinal implant
USD732667S1 (en) 2012-10-23 2015-06-23 Providence Medical Technology, Inc. Cage spinal implant
CN105939677A (en) 2013-12-12 2016-09-14 康文图斯整形外科公司 Tissue displacement tools and methods
WO2015127358A1 (en) * 2014-02-24 2015-08-27 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of prognosis and classification for recovery from surgical trauma
US9867641B2 (en) 2014-05-15 2018-01-16 Brahm Holdings, Llc Spinal graft
WO2015184018A1 (en) 2014-05-28 2015-12-03 Providence Medical Technology, Inc. Lateral mass fixation system
US11461848B1 (en) 2015-01-14 2022-10-04 Alchemy Logic Systems, Inc. Methods of obtaining high accuracy impairment ratings and to assist data integrity in the impairment rating process
US10898590B2 (en) * 2015-09-21 2021-01-26 Kolon Life Science, Inc. Method for delivery of biological molecule to nervous tissue
EP3361966A4 (en) 2015-10-13 2019-07-24 Providence Medical Technology, Inc. Spinal joint implant delivery device and system
USD841165S1 (en) 2015-10-13 2019-02-19 Providence Medical Technology, Inc. Cervical cage
CN105497017B (en) * 2015-11-20 2018-02-23 厦门大学 The pharmaceutical applications of wedelolactone
WO2018005548A1 (en) 2016-06-28 2018-01-04 Providence Medical Technology, Inc. Spinal implant and methods of using the same
USD887552S1 (en) 2016-07-01 2020-06-16 Providence Medical Technology, Inc. Cervical cage
US11853973B1 (en) 2016-07-26 2023-12-26 Alchemy Logic Systems, Inc. Method of and system for executing an impairment repair process
US11854700B1 (en) 2016-12-06 2023-12-26 Alchemy Logic Systems, Inc. Method of and system for determining a highly accurate and objective maximum medical improvement status and dating assignment
EP3624708A1 (en) 2017-05-19 2020-03-25 Providence Medical Technology, Inc. Spinal fixation access and delivery system
US11571429B2 (en) * 2017-05-23 2023-02-07 Upexmed Co. Ltd. Method and compounds for treating peripheral neuropathy
US20180338929A1 (en) * 2017-05-23 2018-11-29 Soon Kap Hahn Method and Compounds for Treating Peripheral Neuropathy
CN110945358B (en) * 2017-05-29 2023-07-25 柏林夏瑞蒂医科大学 CD 8T cell subpopulations as markers for predicting post-spinal fusion non-fusion
US10918426B2 (en) 2017-07-04 2021-02-16 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone
CN111433358A (en) * 2017-07-13 2020-07-17 迈阿密大学 Method for managing pain
US11793836B2 (en) * 2017-09-27 2023-10-24 Inmune Bio Inc Method for treating complications related to acute or chronic hyperglycemia
CN107736956B (en) * 2017-09-30 2023-07-21 四川大学华西医院 Artificial intelligent cervical intervertebral disc capable of recording pressure and motion
US11464804B1 (en) * 2017-11-15 2022-10-11 Enrico Stazzone Intrathecal multifactorial infusion of heterogeneous autologous cell therapy
WO2019136263A1 (en) 2018-01-04 2019-07-11 Providence Medical Technology, Inc. Facet screw and delivery device
US11625687B1 (en) 2018-10-16 2023-04-11 Alchemy Logic Systems Inc. Method of and system for parity repair for functional limitation determination and injury profile reports in worker's compensation cases
USD933230S1 (en) 2019-04-15 2021-10-12 Providence Medical Technology, Inc. Cervical cage
USD911525S1 (en) 2019-06-21 2021-02-23 Providence Medical Technology, Inc. Spinal cage
US11848109B1 (en) 2019-07-29 2023-12-19 Alchemy Logic Systems, Inc. System and method of determining financial loss for worker's compensation injury claims
USD945621S1 (en) 2020-02-27 2022-03-08 Providence Medical Technology, Inc. Spinal cage
WO2022235932A1 (en) * 2021-05-05 2022-11-10 Board Of Regents, The University Of Texas System Methods and compositions for treatment of neuropathic pain using stat3 inhibitors
WO2023244864A1 (en) * 2022-06-17 2023-12-21 Spencer Spence Ozone therapeutic treatment apparatus and method of use to treat a treatment location

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010026801A1 (en) * 1999-02-24 2001-10-04 Tobinick Edward L. Cytokine antagonists for the treatment of localized disorders
US6340369B1 (en) * 1999-08-13 2002-01-22 Bret A. Ferree Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix
US20040022864A1 (en) * 2002-08-05 2004-02-05 Toby Freyman Methods of delivering therapeutic agents
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
IL85035A0 (en) * 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US6586388B2 (en) * 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
NZ235148A (en) * 1989-09-05 1991-12-23 Immunex Corp Tumour necrosis factor receptor protein and dna sequences
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5129900B1 (en) * 1990-07-24 1998-12-29 Acromed Corp Spinal column retaining method and apparatus
JP2818056B2 (en) * 1990-09-07 1998-10-30 森永乳業株式会社 Antimicrobial peptides and antimicrobial agents
US6284471B1 (en) * 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US7192584B2 (en) * 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5763446A (en) * 1992-03-26 1998-06-09 University Of Southern California Use of pentoxifylline and other tumor necrosis factor blockers for the treatment of aids-associated optic neuropathy and other central nervous system diseases
EP0633776B1 (en) * 1992-04-02 2001-05-09 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US6248110B1 (en) * 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US5574022A (en) * 1994-04-14 1996-11-12 The Center For Innovative Technology Method of attenuating physical damage to the spinal cord
FR2722980B1 (en) * 1994-07-26 1996-09-27 Samani Jacques INTERTEPINOUS VERTEBRAL IMPLANT
US5782919A (en) * 1995-03-27 1998-07-21 Sdgi Holdings, Inc. Interbody fusion device and method for restoration of normal spinal anatomy
US6245072B1 (en) * 1995-03-27 2001-06-12 Sdgi Holdings, Inc. Methods and instruments for interbody fusion
US5643915A (en) * 1995-06-06 1997-07-01 Andrulis Pharmaceuticals Corp. Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies
US6406867B1 (en) * 1996-08-16 2002-06-18 Human Genome Sciences, Inc. Antibody to human endokine alpha and methods of use
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6869938B1 (en) * 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6136308A (en) * 1997-09-12 2000-10-24 Vasogen Ireland Limited Treatment of stress and preconditioning against stress
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods
WO1999057303A1 (en) * 1998-05-07 1999-11-11 University Of Maryland, Baltimore A method for diagnosing and treating chronic pelvic pain syndrome
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US7811990B2 (en) * 1998-09-25 2010-10-12 Sciaticon Ab Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus
US7115557B2 (en) * 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
US7906481B2 (en) * 1998-09-25 2011-03-15 Sciaticon Ab Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus
WO2000045870A1 (en) * 1999-02-04 2000-08-10 Sdgi Holdings, Inc. Osteogenic paste compositions and uses thereof
US6982089B2 (en) * 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US6015557A (en) * 1999-02-24 2000-01-18 Tobinick; Edward L. Tumor necrosis factor antagonists for the treatment of neurological disorders
US6423321B2 (en) * 1999-02-24 2002-07-23 Edward L. Tobinick Cytokine antagonists for the treatment of sensorineural hearing loss
US20030113318A1 (en) * 1999-02-24 2003-06-19 Tobinick Edward Lewis TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
US8119127B2 (en) * 1999-02-24 2012-02-21 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
US20030007972A1 (en) * 1999-02-24 2003-01-09 Edward Tobinick Cytokine antagonists and other biologics for the treatment of bone metastases
US7214658B2 (en) * 2004-07-06 2007-05-08 Tact Ip, Llc Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
US6379666B1 (en) * 1999-02-24 2002-04-30 Edward L. Tobinick TNF inhibitors for the treatment of neurological, retinal and muscular disorders
US6245108B1 (en) * 1999-02-25 2001-06-12 Spineco Spinal fusion implant
AU6168699A (en) * 1999-03-24 2000-10-09 Parallax Medical, Inc. Non-compliant system for delivery of implant material
JP4247519B2 (en) * 1999-08-18 2009-04-02 イントリンジック セラピューティックス インコーポレイテッド Apparatus and method for nucleus augmentation and retention
US6592625B2 (en) * 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US6533817B1 (en) * 2000-06-05 2003-03-18 Raymedica, Inc. Packaged, partially hydrated prosthetic disc nucleus
US20060018907A1 (en) * 2000-08-07 2006-01-26 Centocor, Inc. Anti-TNF antibodies and peptides of human tumor necrosis factor
US20050249735A1 (en) * 2000-08-07 2005-11-10 Centocor, Inc. Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor
US6773723B1 (en) * 2000-08-30 2004-08-10 Depuy Acromed, Inc. Collagen/polysaccharide bilayer matrix
US6579319B2 (en) * 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US6375659B1 (en) * 2001-02-20 2002-04-23 Vita Licensing, Inc. Method for delivery of biocompatible material
EP1390757B1 (en) * 2001-02-21 2008-10-08 Stryker Corporation Determining cartilage degeneration and aging using bone morphogenic proteins
US6989031B2 (en) * 2001-04-02 2006-01-24 Sdgi Holdings, Inc. Hemi-interbody spinal implant manufactured from a major long bone ring or a bone composite
US6569201B2 (en) * 2001-09-28 2003-05-27 Depuy Acromed, Inc. Hybrid composite interbody fusion device
AU2002336694A1 (en) * 2001-11-01 2003-05-12 Lawrence M. Boyd Devices and methods for the restoration of a spinal disc
US6582439B1 (en) * 2001-12-28 2003-06-24 Yacmur Llc Vertebroplasty system
US6740118B2 (en) * 2002-01-09 2004-05-25 Sdgi Holdings, Inc. Intervertebral prosthetic joint
US6726720B2 (en) * 2002-03-27 2004-04-27 Depuy Spine, Inc. Modular disc prosthesis
US7004944B2 (en) * 2002-07-16 2006-02-28 Sdgi Holdings, Inc. Bone plate fastener retaining mechanisms and methods
US7588573B2 (en) * 2002-09-23 2009-09-15 Warsaw Orthopedic, Inc. Expansion tool for adjustable spinal implant
US6899735B2 (en) * 2002-10-02 2005-05-31 Sdgi Holdings, Inc. Modular intervertebral prosthesis system
WO2004060212A1 (en) * 2002-12-17 2004-07-22 Bristol-Myers Squibb Company Anti-inflammatory coating for implantable medical devices
WO2004098452A2 (en) * 2003-05-02 2004-11-18 Yale University Dynamic spine stabilizer
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US20050180974A1 (en) * 2003-10-24 2005-08-18 Medtronic, Inc. Extracellular TNF inhibitors for treating CNS disorders
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US7226250B2 (en) * 2003-12-22 2007-06-05 Hayes Lemmerz International, Inc. Tool and method for forming a lug hole
TWI439284B (en) * 2004-04-09 2014-06-01 Abbvie Biotechnology Ltd Multiple-variable dose regimen for treating tnfα-related disorders
US7051451B2 (en) * 2004-04-22 2006-05-30 Archus Orthopedics, Inc. Facet joint prosthesis measurement and implant tools
US7261738B2 (en) * 2004-06-30 2007-08-28 Depuy Spine, Inc. C-shaped disc prosthesis
US20060046960A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US7023188B1 (en) * 2004-09-10 2006-04-04 Semiconductor Components Industries, L.L.C. Method of forming a multi-phase power supply controller
WO2007048105A2 (en) * 2005-10-19 2007-04-26 A Enterprises, Inc. Curable bone substitute
US8197545B2 (en) * 2005-10-27 2012-06-12 Depuy Spine, Inc. Nucleus augmentation delivery device and technique
CA2692428A1 (en) * 2006-07-07 2008-01-10 James R. Gorman Methods for preventing, postponing or improving the outcome of invasive spinal procedures

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010026801A1 (en) * 1999-02-24 2001-10-04 Tobinick Edward L. Cytokine antagonists for the treatment of localized disorders
US6340369B1 (en) * 1999-08-13 2002-01-22 Bret A. Ferree Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix
US20040022864A1 (en) * 2002-08-05 2004-02-05 Toby Freyman Methods of delivering therapeutic agents
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines

Also Published As

Publication number Publication date
CA2697784A1 (en) 2008-01-10
US20080019969A1 (en) 2008-01-24
US20100047235A1 (en) 2010-02-25
WO2008006118A3 (en) 2008-11-20
US20080019970A1 (en) 2008-01-24
US20100040609A1 (en) 2010-02-18
WO2008006106A2 (en) 2008-01-10
CA2692428A1 (en) 2008-01-10
WO2008006117A3 (en) 2008-11-20
WO2008006117A2 (en) 2008-01-10
US20100093829A1 (en) 2010-04-15
US20080019975A1 (en) 2008-01-24
WO2008006118A2 (en) 2008-01-10
CA2692430A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
WO2008006106A3 (en) Methods for preventing, postponing or improving the outcome of invasive spinal procedures
WO2006124880A3 (en) Systems and methods to facilitate endoscopic interventions
WO2008028193A3 (en) Colon-targeted oral formulations of cytidine analogs
WO2012027065A3 (en) Combination therapy for treatment of disease
WO2009064460A3 (en) Gastrointestinal delivery systems
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
BRPI0515819A (en) methods for targeted delivery of genetic material to the liver
WO2008005388A3 (en) Localization of body lumen junctions
WO2009117122A3 (en) Genetic analysis
WO2008087190A3 (en) Use of peptides in combination with surgical intervention for the treatment of obesity
BRPI0921999B8 (en) use of a therapeutically effective amount of placental stem cells
BR112013008140A2 (en) "imidazotriazinone compounds".
WO2007082040A3 (en) Maneuverable ambulance chair
WO2007100672A3 (en) Marker arrangement for bifurcation catheter
WO2003082078A3 (en) Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
WO2010030781A3 (en) Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer
WO2008106646A3 (en) Methods and formulations for topical gene therapy
WO2007117467A3 (en) Use of tm-601 for the diagnosis and treatment of tumors
WO2008083160A3 (en) Methods and compositions for therapeutic treatment
WO2008084239A3 (en) Apparatus for administering therapy at a remote location in the body
NZ599670A (en) Diagnostic and therapeutic methods for rheumatic heart disease based upon group a streptococcus markers
WO2006029142A3 (en) Methods and systems for treating asthma and other respiratory diseases
WO2008020904A3 (en) Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
WO2008103378A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
WO2008016640A3 (en) Use of poloxamer for the prevention and/or treatment of heart failure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07799410

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWE Wipo information: entry into national phase

Ref document number: 12307900

Country of ref document: US

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A OF 22.04.2009

122 Ep: pct application non-entry in european phase

Ref document number: 07799410

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2692428

Country of ref document: CA